LABU Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Oct 28 at 5:59 PM ET (Korea 10/29 06:59)
Full metrics table
| Category | Equity - Leveraged / Inverse | Expense | 0.96% | Return% 1Y | 108.23% | Total Holdings | 174 | Perf Week | 8.53% | Volume | 378,151 |
| Asset Type | Equities (Stocks) | AUM | $636M | Return% 3Y | 63.24% | NAV | $242.24 | Perf Month | -2.62% | Avg Volume | 0.40M |
| ETF Type | US Equities | Dividend TTM | $0.91 (0.36%) | Return% 5Y | -25.1% | 52W High | -25.67% | Perf Quarter | 2.15% | Rel Volume | 0.95 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | -9.55% | 52W Low | 133.38% | Perf Half Y | 51% | Prev Close | $242.25 |
| IPO | 2015/5/28 | Flows% 1M | 14.94% | Return% SI | -19.88% | RSI (14) | 54.88 | Perf YTD | 59.45% | Price | $254.15 |
| Beta | 2.53 | Flows% 3M | 17.51% | Flows% YTD | -38.96% | Flows% 1Y | -51.97% | Perf Year | 97.24% | Volatility(W/M) | 7.61% 8.59% |
| SMA20 | 10.34% | SMA50 | -3.75% | SMA200 | 17.82% | ATR | 20.15 | ||||
Direxion Daily S&P Biotech Bull 3X Shares seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
It moves 3x the daily move of the index
Its value erodes over time. It is built for trades of a day or two, not for holding.
The top 10 make up 68% of the fund
Concentrated in a few names. When they swing, the ETF swings with them.
APGE APOGEE THERAPEUTICS INC 1.11% 6 
ORKA ORUKA THERAPEUTICS INC 1.03% 7 
DNTH DIANTHUS THERAPEUTICS INC 0.96% 8 
ERAS ERASCA INC 0.93% 9 
TWST TWIST BIOSCIENCE CORP 0.92% 10 
KYMR KYMERA THERAPEUTICS INC 0.90% Largest sectors first.
Over the past 1 year, roughly in the middle
26% below its 1-year high.
Traded about as much as usual. That is 95% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -76.9%. The S&P 500 did +69% over the same period.
Tap to view numbers
The price swings wildly
At its worst (February 2021) it fell 99% and has not fully recovered yet.
Tap to view numbers
The dividend is on the small side
Pays 0.36% annually in dividends.
Tap to view numbers
A lot of money is flowing out
Over the past year, money equal to 52.0% of assets left.
Tap to view numbers
MRNY YieldMax MRNA Option Income Strategy ETF 232M 
BIB ProShares Ultra Nasdaq Biotechnology 2X Shares 99M 
LABD-1× Direxion Daily S&P Biotech Bear 3X ETF 61M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
BIS-1× ProShares UltraShort Nasdaq Biotechnology -2x Shares 2M 
TQQQ ProShares UltraPro QQQ 3x Shares 0.78% 
SOXL Direxion Daily Semiconductor Bull 3X ETF 0.75% 
QLD ProShares Ultra QQQ 2x Shares 0.89% 
SSO ProShares Ultra S&P500 2x Shares 0.84% 
SPXL Direxion Daily S&P 500 Bull 3X ETF 0.84% 
TOPW Roundhill Top WeeklyPay ETF 0.32% 
FNGU MicroSectors FANG+ 3X Leveraged ETNs 0.35% 
NRGU MicroSectors U.S. Big Oil 3 Leveraged ETNs 0.35% 
FAQ
How many holdings does LABU have?
LABU holds a total of 174 securities, with an AUM of approximately $636M.
Does LABU pay dividends (distributions)?
LABU's distribution yield is approximately 0.36%.
What is the 52-week high and low for LABU?
LABU has recorded a 52-week high of $341.93 and a low of $108.90.
